Improved Hepanostika, an enzyme-immunoassay for hepatitis B surface antigen

Area of Science:

• Clinical Chemistry
• Immunology
• Virology

Background:

• Hepanostika is an enzyme-immunoassay for Hepatitis B virus (HBV) detection.
• There is a need for improved diagnostic assays regarding speed, sensitivity, and result interpretation.

Purpose of the Study:

• To modify the Hepanostika enzyme-immunoassay to enhance test duration, sensitivity, and result readability.
• To evaluate the performance of two modified assay versions.

Main Methods:

• Two distinct modifications of the Hepanostika assay were developed.
• Modifications involved altering test conditions and assay components, including conjugates.
• Performance was assessed using deep-frozen donor sera.

Main Results:

• The first modification reduced test time to 3 hours and increased sensitivity threefold but lacked specificity for routine screening.
• The second modification, using different conjugates, completed testing in under 4 hours with at least double the sensitivity.
• The second modification demonstrated acceptable specificity (<2% false positives) in preliminary tests with over 500 donor sera.
• Results from the second modification were directly measurable with a photometer.

Conclusions:

• The second modification of Hepanostika offers a promising improvement for HBV detection.
• This enhanced assay provides a balance of speed, sensitivity, and acceptable specificity for donor serum screening.